Delayed Cord Clamping with Oxygen for Premature Birth
(DOXIE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which method of delayed cord clamping helps premature babies (born up to 28 weeks and 6 days) reach a healthy oxygen level faster. The study compares two groups: one receives high oxygen during delayed cord clamping, and the other receives lower oxygen. It seeks participants who are pregnant with single or multiple babies, regardless of delivery method, and who are expected to give birth preterm. As an unphased trial, this study offers a unique opportunity to contribute to important research that could improve outcomes for premature babies.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that delayed cord clamping (DCC) is generally safe for newborns, including those born prematurely. Studies indicate that DCC can increase blood volume, benefiting newborns. One study found that administering 100% oxygen to preterm infants during DCC helped reduce low oxygen levels early on, suggesting it is a well-tolerated method.
For low oxygen levels during DCC, research supports its safety, as DCC itself is linked to better blood flow and improved health outcomes for preterm infants. This includes benefits like better circulation and easier breathing immediately after birth. Overall, both high and low oxygen levels during DCC have been shown to be safe options for newborn care.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the benefits of delayed cord clamping with varying oxygen levels for premature infants. Unlike the standard practice, which typically involves immediate cord clamping and standard oxygen support, this approach tests whether holding off on clamping the cord for 90 seconds while providing either high or low oxygen concentrations can improve outcomes for these vulnerable newborns. The potential difference in how these oxygen levels interact with delayed cord clamping might offer insights into optimizing early care for preemies, potentially improving their adaptation to life outside the womb.
What evidence suggests that this trial's treatments could be effective for premature birth?
Studies have shown that delaying umbilical cord clamping (DCC) benefits preterm infants by improving blood flow and circulation immediately after birth. In this trial, some infants will join the high oxygen group, where research suggests that providing 100% oxygen during DCC can prevent low oxygen levels early on. This method has been linked to better oxygen levels in the first few minutes of life. Infants in the low oxygen group will receive DCC with a lower oxygen concentration, which still offers significant benefits, such as improved blood flow and a reduced risk of death compared to immediate cord clamping. Overall, DCC, whether with high or low oxygen, supports better early health outcomes for preterm infants.12345
Who Is on the Research Team?
Anup Katheria, MD
Principal Investigator
Sharp HealthCare
Are You a Good Fit for This Trial?
This trial is for preterm infants born up to 28+6 weeks gestational age, from any type of delivery and pregnancy. It's not for those with early membrane rupture before 20 weeks, congenital anomalies, fetal/maternal compromise, or if parents decline consent or resuscitation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Infants receive delayed cord clamping with either high or low oxygen concentration for 90 seconds
Initial Monitoring
Infants are monitored for oxygen saturation, heart rate, and other vital signs in the first 24 hours of life
Follow-up
Participants are monitored for safety and effectiveness after the intervention, including assessments for sepsis, intraventricular hemorrhage, and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Delayed Cord Clamping with High Oxygen concentration
- Delayed Cord Clamping with Low Oxygen concentration
Delayed Cord Clamping with High Oxygen concentration is already approved in European Union, United States for the following indications:
- Preterm infants for improved transitional circulation, better establishment of red blood cell volume, decreased need for blood transfusion, and lower incidence of necrotizing enterocolitis and intraventricular hemorrhage
- Term and preterm infants for improved hemoglobin levels, iron stores, and developmental outcomes, and reduced risk of intraventricular hemorrhage and necrotizing enterocolitis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sharp HealthCare
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Sharp Mary Birch Hospital for Women & Newborns
Collaborator